[1]
Moreira, G.S.V.S. et al. 2024. INVESTIGATING THE CARDIOVASCULAR EFFECTS OF NEW GLUCOSE LOWERING AGENTS IN PATIENTS WITH DIABETES AND CORONARY ARTERIAL DISEASE. Revista Ibero-Americana de Humanidades, Ciências e Educação. 10, 6 (Jun. 2024), 1823–1832. DOI:https://doi.org/10.51891/rease.v10i6.14509.